- JP-listed companies
- KYORIN Pharmaceutical Co., Ltd.
- Income statement
KYORIN Pharmaceutical Co., Ltd.【JP:4569】Income statement
Market cap
¥103.3B
P/E ratio
19.1x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 103,232 | 107,031 | 111,400 | 113,121 | 119,483 | 115,373 | 110,640 | 113,620 | 109,983 | 102,904 | 105,534 | 113,270 | 119,532 | 130,087 |
| Cost of revenue | - | - | - | 46,598 | 47,360 | 50,847 | 49,064 | 56,210 | 52,950 | 51,276 | 56,093 | 63,102 | 68,124 | 70,551 |
| Gross profit | - | - | - | 66,522 | 72,122 | 64,526 | 61,576 | 57,409 | 57,032 | 51,627 | 49,441 | 50,167 | 51,408 | 59,535 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 14,737 | 19,636 | 10,413 | 8,822 | 8,972 | 7,503 | 5,786 | 5,007 | 5,123 | 6,013 | 12,567 |
| Operating expenses | - | - | - | 51,785 | 52,486 | 54,113 | 52,753 | 48,436 | 49,528 | 45,841 | 44,433 | 45,043 | 45,394 | 46,967 |
| Income before tax | 15,275 | 18,676 | 18,281 | 15,490 | 19,995 | 10,874 | 9,345 | 9,438 | 8,175 | 6,447 | 5,569 | 5,827 | 6,602 | 13,219 |
| Provision for income taxes | - | - | - | 5,497 | 5,175 | 2,411 | 2,486 | 2,490 | 2,106 | 2,222 | 1,284 | 2,182 | 1,696 | 3,684 |
| Net income | 3,414 | 12,973 | 5,392 | 12,064 | 13,639 | 7,305 | 6,574 | 6,869 | 6,149 | 6,130 | 3,932 | 4,723 | 5,322 | 9,086 |
| Earnings per share | 123.54 | 166.25 | 160.95 | 161.63 | 184.28 | 99.45 | 89.28 | 104.68 | 107.35 | 106.99 | 68.62 | 82.44 | 92.74 | 158.17 |
| Dividend per share | 45 | 50 | 52 | 52 | 58 | 58 | 58 | 75 | 75 | 75 | 52 | 52 | 52 | 57 |